Lenalidomide Maintenance and MRD 100 Days Post ASCT Predict PFS in Real-World Patient Cohort in Brazil

05.29.23

Lenalidomide Maintenance and MRD 100 Days Post ASCT Predict PFS in Real-World Patient Cohort in Brazil

by Eleanor Mayfield, ELS

Individualized Busulfan Dosing Improves Outcomes vs. Fixed Dosing in Pre-Transplant, MRD+, Intermediate-Risk AML Patients Receiving Allo-SCT

05.25.23

Individualized Busulfan Dosing Improves Outcomes vs. Fixed Dosing in Pre-Transplant, MRD+, Intermediate-Risk AML Patients Receiving Allo-SCT

by Eleanor Mayfield, ELS

Value of DNA sequencing pre-HCT for AML patients

05.09.23

Value of DNA sequencing pre-HCT for AML patients

by ASTCT Science Highlights

Pre-Transplant DNA Sequencing Suggests Association Between Persistence of Most-Common AML Variants and Poorer Outcomes in Patients with AML

05.08.23

Pre-Transplant DNA Sequencing Suggests Association Between Persistence of Most-Common AML Variants and Poorer Outcomes in Patients with AML

by Eleanor Mayfield, ELS

ddPCR, NGS “Are Promising Alternative Approaches to MRD Assessment in ALL”

04.19.23

ddPCR, NGS “Are Promising Alternative Approaches to MRD Assessment in ALL”

by Eleanor Mayfield, ELS

Nanopore-Based Monitoring of Cell-Free DNA “Possible Biomarker in B-ALL”

04.11.23

Nanopore-Based Monitoring of Cell-Free DNA “Possible Biomarker in B-ALL”

by Eleanor Mayfield, ELS

Study Finds Prognostic Impact of MRD Is Universal Across Treatment Regimens in Pediatric ALL, Regardless of When It Is Measured

04.03.23

Study Finds Prognostic Impact of MRD Is Universal Across Treatment Regimens in Pediatric ALL, Regardless of When It Is Measured

by Eleanor Mayfield, ELS

MRD in ASC samples linked to high risk of relapse post-ASCT in R/R DLBCL

02.07.23

MRD in ASC samples linked to high risk of relapse post-ASCT in R/R DLBCL

by ASTCT Science Highlights

Detectable MRD Associated with Increased Relapse Risk in AML Patients Treated With RIC, But Not MAC, Before Allo-HCT

02.02.23

Detectable MRD Associated with Increased Relapse Risk in AML Patients Treated With RIC, But Not MAC, Before Allo-HCT

by Eleanor Mayfield, ELS

Theme picker